Does text messaging help with medication adherence in chronic disease?

Medication adherence in chronic disease is poor. Can telephone text messaging help with adherence? A new article published online by JAMA Internal Medicine examines the question in a meta-analysis conducted by Jay Thakkar, F.R.A.C.P., and Clara K. Chow, Ph.D., of The George Institute for Global Health, the University of Sydney, Australia, and coauthors.

The meta-analysis included 16 to assess the effect of text messaging on medication adherence in chronic disease.

The results suggest text messaging was associated with increased odds of medication adherence. However, the authors encourage caution when interpreting their results, in part, because of the reliance on self-reported . The authors recommend future studies with a focus on appropriate patient populations, the longevity of the effect and the influence on clinical outcomes.

In a related commentary, R. Brian Haynes, M.D., Ph.D., of McMaster University, Hamilton, Ontario, Canada, and coauthors write: "In summary, future adherence research needs to overcome the common methodological pitfalls that are still plaguing the field. As Thakkar et al show, TM [text messaging] has potential as a widespread, low-cost technology but will need more development and rigorous testing to determine if it has real, enduring and patient-important benefits that are worth the investment."


Explore further

Review: mHealth text messages promote medication adherence

More information: JAMA Intern Med. Published online February 1, 2016. DOI: 10.1001/jamainternmed.2015.7667
Journal information: JAMA Internal Medicine

Citation: Does text messaging help with medication adherence in chronic disease? (2016, February 1) retrieved 18 April 2021 from https://medicalxpress.com/news/2016-02-text-messaging-medication-adherence-chronic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments